Aspirin protects against colon cancer, Pitt study shows |

Aspirin protects against colon cancer, Pitt study shows

Doctors have known for years that taking aspirin might reduce the risk of colon cancer by as much as 50 percent — they just didn’t know how the science works.

A study based at the University of Pittsburgh Cancer Institute has spotted a biological mechanism that could unravel the mystery, a discovery that might lead to better treatments with fewer side effects, researchers announced Monday.

The disease ranks as the second-leading cause of cancer-related fatalities nationwide and is projected to kill 50,000 people in 2014.

“If you can reduce the risk of colon cancer by significant fractions or (a small) percentage, that saves the lives of a lot of people,” said senior investigator Lin Zhang, an associate professor at the cancer institute and the Pitt School of Medicine.

His five-year collaboration with researchers at Pitt and two other schools shows that aspirin and other common painkillers such as ibuprofen can trigger self-destruction of cells that might lead to cancerous tumors. Their findings appear online in the Proceedings of the National Academy of Sciences, a research journal.

Zhang said researchers will use the information to try to refine preventive treatments for those at high risk of colon cancer. An estimated 136,830 people in the United States will be diagnosed this year, according to the American Cancer Society.

“Basically, you sort out the good things and hopefully mitigate the bad things. In that way, I think — hopefully — we’ll improve the preventive effects of those drugs,” Zhang said.

Chronic use of the painkillers reviewed in the study, known as nonsteroidal anti-inflammatory drugs, can cause dangerous complications, including gastrointestinal bleeding and ulcers.

Those side effects have long worried doctors, said Dr. Otis Brawley, chief medical officer at the American Cancer Society in Atlanta. He said people on aspirin therapy can bruise more easily and can have a higher chance of hemorrhagic stroke.

Still, a separate study in 2011 found that aspirin use cut the risk of cancer-related death by about 20 percent for participants in the research, according to the National Cancer Institute. The institute said several ongoing clinical trials are exploring aspirin’s effects on cancer risk in more detail.

“Given the fact that it decreases the risk of heart attack death, it’s an amazing substance,” Brawley said.

But people should rely on doctors’ recommendations before adopting an aspirin regimen, Zhang said.

He said $2 million to $3 million in funding from the National Institutes of Health helped finance his team’s latest work and related research. The American Cancer Society and Pitt assisted.

Adam Smeltz is a staff writer for Trib Total Media. He can be reached at 412-380-5676 or [email protected].

TribLIVE commenting policy

You are solely responsible for your comments and by using you agree to our Terms of Service.

We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.

While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.

We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers

We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.

We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.

We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.

We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.